2018
DOI: 10.1007/s00403-018-1852-6
|View full text |Cite
|
Sign up to set email alerts
|

Heme oxygenase and iron status in exosomes of psoriasis patients

Abstract: Psoriasis is an autoimmune skin disease characterized by hyperproliferation of keratinocytes due to interplay between keratinocytes and immune cells. Iron status plays an important role in modifying the function of the immune system. Heme oxygenase (HO), heme-degrading enzyme, plays important role in protective response to oxidative cellular stress. We aimed in this study to map the iron status and HO levels and declare the role HO enzyme in iron homeostasis and immune-modulation in psoriasis. Fifty-one patien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 23 publications
0
10
0
Order By: Relevance
“…HAMP binds to FPN and induces its internationalization and subsequent degradation, thereby reducing Fe release from macrophages and enterocytes [28]. FTH1 is a subunit of ferritin, an Fe-storage protein [29], and HMOX is an enzyme involved in heme catabolism, both of which are regulated by host Fe status [30]. NRF2, a regulator of the antioxidant response, also regulates FTH1 and FPN to maintain cellular Fe homeostasis [31].…”
Section: Resultsmentioning
confidence: 99%
“…HAMP binds to FPN and induces its internationalization and subsequent degradation, thereby reducing Fe release from macrophages and enterocytes [28]. FTH1 is a subunit of ferritin, an Fe-storage protein [29], and HMOX is an enzyme involved in heme catabolism, both of which are regulated by host Fe status [30]. NRF2, a regulator of the antioxidant response, also regulates FTH1 and FPN to maintain cellular Fe homeostasis [31].…”
Section: Resultsmentioning
confidence: 99%
“…This upper band may represent either bound NADPH:cytochrome P450 reductase (Linnenbaum, Busker, Kraehling, & Behrends, 2012; Sato, Kato, & Arawaka, 2013), a key electron donor in the HO‐1‐catalyzed heme degradation pathway, or a multimeric form of HO‐1 (Hwang et al., 2009; Linnenbaum et al., 2012). Others have shown the presence of HO‐1 mRNA in EVs (El‐Rifaie et al., 2018), and mass spectrometry analyses have identified HO‐1 in proteomic profiles of healthy human urinary EVs (Wang et al., 2012) as well as EVs released by various cancer cells (Kalra et al., 2012). In contradistinction to EV HO‐1, total extracellular HO‐1 has been studied extensively as a potential biomarker in various disease states.…”
Section: Discussionmentioning
confidence: 99%
“…The presence of HO‐1 messenger RNA (mRNA) or protein in EVs has been minimally described in the literature. El‐Rifaie and colleagues reported increased HO‐1 mRNA in exosomes isolated from peripheral blood mononuclear cells of psoriasis patients (El‐Rifaie, Sabry, Doss, Kamal, & Abd El Hassib, 2018). Furthermore, exosomes released from bovine granulosa cells challenged with hydrogen peroxide in vitro resulted in significant elevation of nuclear factor erythroid 2‐related factor 2 mRNA and downstream antioxidants (e.g., catalase, thioredoxin), though lower levels of HO‐1 mRNA were recorded (Saeed‐Zidane et al., 2017).…”
Section: Introductionmentioning
confidence: 99%
“…More recently, the involvement of extracellular vesicles (EVs), such as exosomes and micro-vesicles, as potential sources of extracellular biomarkers has been considered [ 104 , 105 ]. In this context, HO-1 mRNA and protein have been detected in exosomes isolated from peripheral blood mononuclear cells (PMBC) of psoriasis patients [ 106 ]. Schipper and coworkers detected HO-1 protein in EVs from various human bio fluids [ 107 ].…”
Section: Ho-1 Gene Transcription and Protein Localizationmentioning
confidence: 99%